Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $22.82 USD
Change Today +0.26 / 1.15%
Volume 25.4K
HGR On Other Exchanges
Symbol
Exchange
Berlin
As of 10:56 AM 03/30/15 All times are local (Market data is delayed by at least 15 minutes).

hanger inc (HGR) Snapshot

Open
$22.71
Previous Close
$22.56
Day High
$23.10
Day Low
$22.51
52 Week High
04/4/14 - $35.41
52 Week Low
11/17/14 - $18.25
Market Cap
805.3M
Average Volume 10 Days
334.8K
EPS TTM
$1.66
Shares Outstanding
35.3M
EX-Date
--
P/E TM
13.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for HANGER INC (HGR)

Related News

No related news articles were found.

hanger inc (HGR) Related Businessweek News

No Related Businessweek News Found

hanger inc (HGR) Details

Hanger, Inc. provides orthotic and prosthetic (O&P) patient care services, distributes O&P devices and components, manages O&P networks, and offers therapeutic solutions in the United States. It operates in two segments, Patient Care, and Products & Services. The Patient Care segment owns and operates O&P patient care clinics; and manages an O&P provider network that coordinates various aspects of O&P patient care for insurance companies. It also designs, fabricates, fits, and maintains a range of custom-made braces and other devices, including spinal, knee, and sports-medicine braces that provide external support to patients suffering from musculoskeletal disorders, such as ailments of the back, extremities or joints, and injuries from sports or other activities. In addition, this segment provides custom-made artificial limbs for patients, who are without limbs as a result of traumatic injuries, vascular diseases, diabetes, and cancer or congenital disorders. The Products & Services segment distributes O&P components to independent customers and its patient care clinics; fabricates and distributes therapeutic footwear for diabetic patients in the podiatric market; and provides specialized rehabilitation technologies and integrated clinical programs for post-acute rehabilitation to long-term care facilities and other sub-acute rehabilitation providers. It also offers V-Hold, a vacuum technology used in lower extremity prosthetic devices; and WalkAide system, which benefits patients with foot drop condition due to spinal cord injuries. As of December 31, 2013, the company provided O&P patient care services through approximately 740 patient care clinics and 1,300 clinicians in 45 states and the District of Columbia. The company was formerly known as Hanger Orthopedic Group, Inc. and changed its name to Hanger, Inc. in June 2012. Hanger, Inc. was founded in 1861 and is headquartered in Austin, Texas.

4,800 Employees
Last Reported Date: 04/4/14
Founded in 1861

hanger inc (HGR) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $620.4K
President of Southern Prosthetic Supply Inc a...
Total Annual Compensation: $307.6K
Vice President, General Counsel and Secretary
Total Annual Compensation: $289.9K
Compensation as of Fiscal Year 2013.

hanger inc (HGR) Key Developments

Hanger, Inc. Receives Non-Compliance Notice From NYSE

Hanger, Inc. announced that, as a result of its failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2014, it has received a notice from the New York Stock Exchange (NYSE) that the company is not in compliance with the NYSE’s continued listing requirements under the timely filing criteria outlined in Section 802.01E of the NYSE Listed Company Manual. The company is also still working to complete and file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2014 as well as to prepare restated financial statements and amended periodic reports for certain other prior periods. The NYSE has informed the company that, under the NYSE’s rules, the company will have six months, until September 17, 2015, to file its Form 10-K with the SEC. The company can, and intends to, regain compliance with the NYSE listing standards prior to such date by filing the Form 10-K with the SEC. If the company fails to file the Form 10-K prior to the NYSE’s compliance deadline, then the NYSE may grant, at its discretion, an extension of up to six additional months for the company to regain compliance, depending on the specific circumstances. The letter from the NYSE also notes that the NYSE may nevertheless commence delisting proceedings at any time if it deems that the circumstances warrant. The NYSE notice has no immediate effect on the listing of the company’s common stock and it continues to be listed on the NYSE. The NYSE previously assigned the company’s symbol an ‘LF’ indicator to signify the company’s late filing status when the company did not timely file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2014.

Hanger, Inc. announced delayed annual 10-K filing

On 03/02/2015, Hanger, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Hanger, Inc. Announces Restatement of Financial Results for the Three Months Ended March 31, 2014, Six Months Ended June 30, 2014, Three Months Ended March 31, 2013, Three Months Ended September 30, 2013, Three Months Ended December 31, 2013, Six Months Ended June 30, 2013, Nine Months Ended September 30, 2013, Three Months Ended March 31, 2012 and Six Months Ended June 30, 2012

Hanger, Inc. announced restatement of financial results for the three months ended March 31, 2014, six months ended June 30, 2014, three months ended March 31, 2013, three months ended September 30, 2013, three months ended December 31, 2013, six months ended June 30, 2013, nine months ended September 30, 2013, three months ended March 31, 2012 and six months ended June 30, 2012. For the three months ended March 31, 2014, the company reported restated pre-tax income of $6,013,000 against $9,932,000 as previously reported. Restated net income was $3,536,000 against $5,997,000 as previously reported. Restated diluted income per share was $0.10 against $0.17 as previously reported. For the six months ended June 30, 2014, the company reported restated pre-tax income of $27,650,000 against $30,134,000 as previously reported. Restated net income was $17,061,000 against $18,616,000 as previously reported. Restated diluted income per share was $0.48 against $0.52 as previously reported. For the three months ended March 31, 2013, the company reported restated pre-tax income of $11,924,000 against $14,939,000 as previously reported. Restated net income was $7,597,000 against $9,490,000 as previously reported. Restated diluted income per share was $0.22 against $0.27 as previously reported. For the three months ended September 30, 2013, the company reported restated pre-tax income of $31,200,000 against $33,889,000 as previously reported. Restated net income was $19,962,000 against $21,659,000 as previously reported. Restated diluted income per share was $0.56 against $0.61 as previously reported. For the three months ended December 31, 2013, the company reported restated pre-tax income of $33,731,000 against $29,625,000 as previously reported. Restated net income was $20,944,000 against $18,356,000 as previously reported. Restated diluted income per share was $0.59 against $0.52 as previously reported. For the six months ended June 30, 2013, the company reported restated pre-tax income of $34,358,000 against $37,230,000 as previously reported. Restated net income was $21,762,000 against $23,569,000 as previously reported. Restated diluted income per share was $0.62 against $0.67 as previously reported. For the nine months ended September 30, 2013, the company reported restated pre-tax income of $65,557,000 against $71,119,000 as previously reported. Restated net income was $41,724,000 against $45,228,000 as previously reported. Restated diluted income per share was $1.18 against $1.28 as previously reported. For the three months ended March 31, 2012, the company reported restated pre-tax income of $11,051,000 against $13,960,000 as previously reported. Restated net income was $6,830,000 against $8,636,000 as previously reported. Restated diluted income per share was $0.20 against $0.25 as previously reported. For the six months ended June 30, 2012, the company reported restated pre-tax income of $39,107,000 against $42,001,000 as previously reported. Restated net income was $24,224,000 against $26,021,000 as previously reported. Restated diluted income per share was $0.70 against $0.75 as previously reported.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HGR:US $22.82 USD +0.26

HGR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HGR.
View Industry Companies
 

Industry Analysis

HGR

Industry Average

Valuation HGR Industry Range
Price/Earnings 13.7x
Price/Sales 0.8x
Price/Book 1.3x
Price/Cash Flow 8.1x
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HANGER INC, please visit www.hanger.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.